netupitant; fosnetupitant

^[1]^[2]

Indications

used in combination with palonosetron in the treatment of nausea & vomiting associated with chemotherapy^[1]

↑ ^1.0 ^1.1 Calcagnile S1, Lanzarotti C, Rossi G et al Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of palonosetron and impact of the fixed dose combination of netupitant and palonosetron when coadministered with ketoconazole, rifampicin, and oral contraceptives. Support Care Cancer. 2013 Oct;21(10):2879-87 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23748441
↑ Pharmacy News. Oct 14, 2014 Netupitant-Palonosetron Combination Approved by FDA. http://www.ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?id=4118